miR-21 may Act as a Potential Mediator Between Inflammation and Abnormal Bone Formation in Ankylosing Spondylitis Based on TNF-α Concentration-Dependent Manner Through the JAK2/STAT3 Pathway
Objective: To explore the role of microRNA (miR-21) in new bone formation in ankylosing spondylitis (AS) as mediated by different concentration of tumor necrosis factor-α (TNF-α). Methods: Fibroblasts isolated from the hips of patients with AS were induced to osteogenesis. These cells were then stim...
Main Authors: | Yu-Cong Zou, Li-Man Yan, Yan-Ping Gao, Zhi- Yun Wang, Gang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-01-01
|
Series: | Dose-Response |
Online Access: | https://doi.org/10.1177/1559325819901239 |
Similar Items
-
IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis
by: Sungsin Jo, et al.
Published: (2018-06-01) -
TNF-alpha antagonists for treatment of juvenile ankylosing spondylitis
by: Kiss EV, et al.
Published: (2011-09-01) -
Recommendations for starting anti TNF-α in patients with ankylosing spondylitis
by: L. Olivieri, et al.
Published: (2003-12-01) -
Three kinds of TNF alpha antagonists in the treatment of ankylosing spondylitis
by: Yu Zhao, et al.
Published: (2018-10-01) -
Treat Ankylosing Spondylitis with Methazolamide
by: Xiaotian Chang, Xinfeng Yan, Yunzhong Zhang
Published: (2011-01-01)